Detail
LncRNA Name | PCA3 |
Synonyms | PCA3, DD3, NCRNA00019, PCAT3 |
Region | GRCh38_9:76691980-76863307 Sequence |
Ensembl | ENSG00000225937 |
RefSeq | NR_015342 |
Circulating | ✔ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | qPCR, Northern blot etc. |
Sample | prostate cancer tissues, cell lines (LNCap-AD, 22Rv1, PC-3, DU145, C4-2 etc.) |
Expression Pattern | up-regulated |
Function Description | qPCR was used to assess the PCA3 and MALAT-1 expression levels in an additional set of 10 pairs of PCa and adjacent normal tissues. Comparing the PCA3 and MALAT-1 expression levels in the 10 paired tissue samples revealed that PCA3 and MALAT-1 were highly expressed in most of the PCa tissues. Plasma lncRNAs probably exist in the form of fragments in a stable form. MD-miniRNA enters cell culture medium at measurable levels, and MD-miniRNA derived from human PCa xenografts actually enters the circulation in vivo and can be measured to distinguish xenografted mice from controls. |
Pubmed ID | 23726266 |
Year | 2013 |
Title | Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. |
External Links |
Links for PCA3 | GenBank HGNC lncrnadb Noncode |
Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.